Conus regius-Derived Conotoxins: Novel Therapeutic Opportunities from a Marine Organism.

Margiotta, Francesco et al.·Marine drugs·2022·
RPEP-063542022RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

C. regius-derived conotoxins show high potency and selectivity against nicotinic acetylcholine receptors.

Key Numbers

How They Did This

The study provides an overview of the pharmacological features and molecular mechanisms of conotoxins, along with proposed chemical engineering solutions.

Why This Research Matters

Understanding and improving conotoxins could lead to new treatments for serious conditions like pain and addiction. Their unique properties make them valuable for drug development.

What This Study Doesn't Tell Us

The study highlights species-specific differences and the challenges of stability and bioavailability in clinical settings.

Trust & Context

Original Title:
Conus regius-Derived Conotoxins: Novel Therapeutic Opportunities from a Marine Organism.
Published In:
Marine drugs, 20(12) (2022)
Database ID:
RPEP-06354

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-06354·https://rethinkpeptides.com/research/RPEP-06354

APA

Margiotta, Francesco; Micheli, Laura; Ciampi, Clara; Ghelardini, Carla; McIntosh, J Michael; Di Cesare Mannelli, Lorenzo. (2022). Conus regius-Derived Conotoxins: Novel Therapeutic Opportunities from a Marine Organism.. Marine drugs, 20(12). https://doi.org/10.3390/md20120773

MLA

Margiotta, Francesco, et al. "Conus regius-Derived Conotoxins: Novel Therapeutic Opportunities from a Marine Organism.." Marine drugs, 2022. https://doi.org/10.3390/md20120773

RethinkPeptides

RethinkPeptides Research Database. "Conus regius-Derived Conotoxins: Novel Therapeutic Opportuni..." RPEP-06354. Retrieved from https://rethinkpeptides.com/research/margiotta-2022-conus-regiusderived-conotoxins-novel

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.